Global Injectable Drug Delivery Device Market 2019-2025
発行: Orion Market Research Pvt Ltd
Global Injectable Drug Delivery Device
Market Size, Share & Trends Analysis Report by Device Type (Conventional Drug Delivery Devices and Self-Injectable Drug Delivery Devices), by Application (CVD, Diabetes, Oncology, General Medication, Vaccination, and Others), and by End-User (Hospitals, Ambulatory Centers, Clinics, and Homecare) and Forecast 2019-2025.
The global injectable drug delivery device market is growing at a significant CAGR during the forecast period. Increasing cases and their treatment of chronic diseases including CVD, cancer, diabetes, and other major diseases is one of the major factors for the growth of the market. For instance, according to the Centers for Disease Control and Prevention (CDC), in the US, alone there were 30 million people have diabetes in 2017; whereas, around 84 million people have prediabetes. Growing awareness of vaccination is further augmenting the demand for injectable drug delivery devices across the globe. A major factor limiting the growth of the market is unsafe injection practices by the physicians. Growing adoption of self-injectable drug delivery devices in emerging economies, such as China and India, is expected to act as an opportunity for market growth.
The injectable drug delivery device market is segmented on the basis of device type, application, and end-user. Based on device type, the market is bifurcated into conventional drug delivery devices and self-injectable drug delivery devices. Self-injectable syringes are forecast to rise with a significant growth rate in the market due to the growing adoption of prefilled syringes across the globe. Based on the application, the market is segmented into CVD, diabetes, oncology, general medication, vaccination, and others. Based on end-user, the market is segmented into hospitals, ambulatory centers, clinics, and homecare. Among these end-users, the homecare segment is expected to show a considerable growth rate in the market due to increasing homecare-based injectables, such as insulin patch pumps.
Geographically, the global injectable drug delivery device market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to hold a significant share in the global market due to the availability of patented drugs, awareness toward diseases and vaccination, and increasing adoption of self-injecting drug devices. Asia-Pacific is expected to propel with a significant growth rate in the global market during the forecast period. Rising awareness toward vaccination, increasing health insurance penetration, and rising incidences of chronic diseases are expected to provide lucrative growth to the market in the near future.
The key companies operating in the global injectable drug delivery device market include: Cardinal Health, Inc., Gerresheimer AG, Schott AG, Becton, Dickinson and Co., Wilhelm Haselmeier GmbH & Co. KG, and Pfizer Inc. The market players are significantly contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market. For instance, in January 2019, Sandoz Inc., a subsidiary of Novartis introduced SYMJEPI (epinephrine) 0.3 mg injection in the US market. The injection is for emergency treatment of allergic reactions including anaphylaxis.
The market study of the global injectable drug delivery device market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
The report is intended for drug manufacturers, injectable device manufacturers, contract manufacturers, government organizations for the overall market and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.